Sprague-Dawley CD rats received daily oral doses (45 mg/kg) of the cationic amphiphilic tricyclic antidepressant imipramine HCI (Tofranil 0) for up to two years. Representative specimens of liver, lung, spleen, mesenteric lymph node, retina and dorsal root ganglion were examined for myeloid bodies (MB). The extent that MB affected a given cell or group of cells was qualitatively determined. Myeloid bodies were observed in a variety of cell types after one year of administration to treated rats. They were less common after a subsequent three month recovery period. Fewer MB were observed in rats treated for one year than were previously reported in short term studies. Fewer MB were seen after two years of treatment than after one year although the same organs were affected. Thus, MB appear to decrease in number with increasing time of compound administration. This may result from a more efficient metabolism of the drug or because of decreased levels of phospholipid in aged rats.
NTRODUCTION
Imipramine hydrochloride is the active ingredient of Tofranil @. It is a tricyclic antidepressant and has also been used to treat enuresis. This antidepressant drug counteracts biogenic amine deficiency at central nervous system (CNS) receptors by blocking the uptake of these amine transmitters into presynaptic neurons thus providing a larger supply of biogenic amines to CNS receptors (9) . The mechanism by which it controls enuresis is not known (7) .
Imipramine HCl and other tricyclic antidepressants are considered amphiphilic cationic drugs (amphiphiles) because of their apolar, aromatic ring system which is hydrophobic and attached hydrophilic cationic side chain (Fig. 1 ). Amphiphiles are a therapeutically diverse group of compounds which include anorectics, inhibitors of cholesterol biosynthesis, antihistaminics and coronary vasodilators, among others.
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Ultrastructural and biochemical studies in man and laboratory animals have shown that amphiphiles induce cellular alterations in various tissues (24). The changes found in these studies resemble the generalized phospholipidoses found in some inborn lysosomal storage diseases in humans. Based on these observations, the concept of a drug-induced lysosomal storage disorder characterized by the formation of tight lipid-drug complexes within lysosomes was introduced (16, 30). These complexes interfere with intralysoso-ma1 enzymatic digestion of polar lipids producing abnormal-appearing secondary lysosomes known as multilamellar inclusion bodies or myeloid (myelinoid) bodies (MB). Myeloid bodies have been described as ". . . single, mem brane-limi ted particles containing smooth membranes in concentric or reticular arrangement" (13). They can occur spontaneously and their formation is generally considered reversible on cessation of drug treatment (6, 13, 16, 17, 24) . The mechanisms of drug-induced intralysosomal lipid storage as well as the morphologic and biochemical characterization of resulting MB have been discussed in detail elsewhere (2-6,lO-31) . The ability to induce lysosomal phospholipidosis and MB formation depends on the amphiphilia of a drug molecule rather than its pharmacologic action (2, 11, 24) . Most studies on the MB-inducing properties of amphiphiles, including imipramine, have involved short term administration of test material to rats (14, 18, 24) . One longer term study using imipramine has been reported (10). The present experiment was limited; it was conducted as part of a two-year carcinogenicity study (unpublished results). Tissues from rats which received relatively low doses (4 mg/kg) of imipramine HC1 for up to two years were evaluated ultrastructurally to determine the general, long term effects of this amphiphile on the occurrence of myeloid bodies.
METHODS
Imipramine HC1 was mixed in Purina Laboratory Chow at dose levels designed to provide 45 mg/kg/day. This mixture was offered free choice to twelve male and female Sprague-Dawley CD rats for up to two years (Table I) . Daily intake of the drug at this dosage was assured for each animal by adjusting drug concentration in the feed relative to daily food consumption and body weight changes. This treatment level exceeded the usual human adult daily dose by approximately 1 0~ as is usual for a chronic toxicity study. Control animals were given powdered feed without the test material.
Rats were housed individually in wire-bottom, suspended cages in a room maintained at 74°F f 4°F and 40-70% relative humidity. An artificial 12 hour light cycle was maintained. Rats received water via an automatic delivery system.
Rats were killed at intervals of one year, three months recovery after one year and two years. Representative portions of liver, lung, spleen, mesenteric lymph node, retina and dorsal root ganglion from treated and control male and female rats were diced in cold fixative. Millonig's-buffered 3% glutaraldehyde or cacodylate-buffered 2.5% glutaraldehyde were used. Specimens were post-fixed in 1% osmium tetroxide, dehydrated in acetone, embedded in Araldite @ and evaluated by transmission electron microscopy. A minimum of two animals from treated and control groups were evaluated at each period. Toluidine bluestained semi-thick sections of specimens (0.5-1.0 pm) were cut with glass knives on a Sorvall Blum MT-I ultramicrotome and examined for orientation purposes. Ultrathin sections of tissue were obtained with a diamond knife on a Sorvall Blum MT-I1 ultramicrotome and were mounted on copper grids. Grids were doublestained with uranyl acetate and lead citrate and examined with a Zeiss 9s-2 transmission electron microscope. Ten to fifteen grid specimens of each tissue were examined per rat. The extent that myeloid bodies affected a specific cell type was qualitatively determined.
RESULTS
Cells from male and female rats treated with imipramine HCl for up to two years appeared morphologically intact although minimal numbers of myeloid bodies were seen. These abnormal cytoplasmic inclusions occurred primarily as multilamellar MB or, occasionally, as reticular MB (Fig. 2 ). Multilamellar MB were characterized by a periodic banding pattern of alternately electron-dense and electron-lucent membranes surrounded by a thicker limiting membrane. Reticular MB were observed most often in lung bronchiolar epithelium and were characterized by a lattice or net-like pattern of tubular subunits within a limiting membrane (Fig. 2 ). Both multilamellar and reticular MB were unicentric or multicentric and occurred in a variety of cells ( Myeloid bodies were observed occasionally after one year of treatment, but were not seen as commonly after the three month recovery period. Fewer MB were seen after two years of treatment than after one year of treatment and fewer cells were affected, although the same organs were involved at each time interval. The morphologic appearances of MB, as well as their distribution and intracellular concentration among the various affected cell types, did not differ between male and female rats.
Of those organs examined, the most commonly affected were, in descending order: mesenteric lymph node, spleen, liver, lung, dorsal root ganglion and retina. Occasional specimens of skeletal muscle contained MB. Lymphocytes in spleen and mesenteric lymph node were most often affected ( Fig. 5 ) but lung alveolar macrophages, when affected, contained the greatest concentration of MB (Fig.  4) . Ganglion cells and pigmented epithelial cells in the retina were free of MB. Few MB were seen in retina and these occurred in photoreceptor cells in a treated rat at the twoyear interval.
The following ultrastructural components had to be distinguished from myeloid bodies: lamellar bodies in type I1 pneumocytes; residual bodies and heterogeneous dense bodies which were rich in membranous material; lipofuscin granules containing membranous material: vacuoles and neutral fat droplets containing loosely-bound, concentric membranes; and myelin figure artifacts induced by glutaraldehyde fixation.
Light microscopic findings during the car-cinogenicity study (unpublished results) were compatible with ultrastructural observations in lung. Imipramine HC1 produced a statistically significant increase (p I 0.05) in the number of rats with lungs containing microscopic foci of foamy macrophages after one and two years of treatment compared to control animals. Ultrastructurally, this increase coincided with the presence of numerous myeloid bodies in alveolar macrophages. The number of rats containing microscopic foci of foamy lung macrophages was diminished at the end of the recovery period. This finding corresponded with the absence of MB in specimens from recovery animals.
DISCUSSION
The myeloid bodies observed in treated male and female rats were considered to be drug-induced. Myeloid body morphology and affected cell types corresponded with what has been described in the literature (3, 4, 6, 10, (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (30) (31) (32) . Generally they were present in small numbers and did not appear to adversely affect those cells in which they were seen. According to Hruban (13) , drug-induced accumulations of MB do not usually cause cell injury in subacute experiments. This also appears to be true in long term studies with imipramine HC1 in which affected cells re-mained morphologically intact. The lung alveolar macrophage is a good example. It appeared to contain the largest concentration of MB yet maintained functional integrity as judged by its physical appearance. Many normal primary and secondary lysosomes were seen in affected macrophages (Fig. 3) suggesting an adequate supply of hydrolytic enzymes for normal cell activity and homeostasis. This finding is important since lysosomes are expended during MB formation (24). Pseudopo- dia of affected macrophages also appeared normal (Fig. 3) , which suggests that movement was not impaired by the physical presence of MB.
Myeloid bodies were most often observed in lymphocytes from mesenteric lymph node and spleen. These cells, both in peripheral blood and from lymphoid tissue, are known to be particularly sensitive to drug-induced phospholipidosis (16, 20) .
Amphiphiles, such as imipramine, are known to induce pronounced phospholipidosis and MB formation in the retinal pigment epithelium (18, 23, 25) . This was not the case following long-term treatment with imipramine HC1 in which scanty MB were found only in photoreceptor cells. Pigment epithelium appeared normal. The reason for this is not known.
Few MB were seen in cells from rats treated for one year and allowed to recover for three months. This supports the known fact that MB disappear after discontinuation of treat-ment with amphiphiles (12, 24). Myeloid bodies are thought to disappear by a gradual dissociation between the drug-lipid complexes within lysosomes. The most widely accepted hypothesis on drug-lipid interaction postulates that the drug binds primarily to acidic polar phospholipids by non-covalent hydrophobic and electrostatic bonding (2, 4,  27) . When the drug is discontinued, its concentration becomes lower extracellularly and a diffusion gradient develops which favors drug-lipid dissociation and movement of drug out of the cell. Intralysosomal digestion of phospolipid resumes, MB disappear and lipid content in the cell returns to normal.
Few MB were observed in cells from rats treated with imipramine HC1 for one year. Even fewer were seen in animals treated for two years although the number and type of organ affected were similar. These findings do not agree with those reported in previous short term studies in which amphiphiles were given to rats at doses of 40-160 mg/kg (24). ~0 1 . 1 1 , NO. 1,1983 MYELOID BODIES AND IMIPRAMINE For example, gave up to 150 mg/kg of several tricyclic compounds, including imipramine HCl, to rats for up to four weeks. Numerous MB were observed in liver, lung, lymphatic tissues, pigment epithelium and ganglion cells of retina, and other tissues. This difference may be due to the two to three fold increase in dosage (45 mg/kg vs. 100-150 mg/kg). It is also possible that cells from rats exposed to long term drug treatment were able to metabolize the drug more efficiently or were exposed to decreased levels of phospholipid so that fewer MB were seen. Comparison of results from short term studies versus long term studies also suggest that MB diminish with increasing time of drug administration. Two studies on the affects of imipramine in the CNS have been reported. In one short term experiment (14), rats received 60 mg/kg of compound intraperitoneally. Myeloid bodies were observed in the pyramidal neurons of the hippocampus. A relatively long term study involved the histological, histochemical and ultrastructural examination of rat brain following oral administration of 50 mg/kg/day for three and six months (10) . No alterations were reported at either time interval. In another study, rats were treated with the anorectic amphiphile chlorphentermine HC1 at 400 mg/litre in drinking water for up to 1 year (31). Within a short time (days to weeks), marked accumulation of foamy alveolar lung macrophages were seen producing the microscopic lesion of "chlorphentermine lung." Ultrastructurally, these cells were packed with MB. With prolonged administration (months), foamy macrophages broke down to form amorphous intra-alveolar debris resembling the granular precipitate of alveolar proteinosis in humans. As chronic administration of chlorphentermine HC1 continued, foam cells actually began to disappear.
An enhanced metabolic adaptive response by cells exposed to long term drug treatment could account for the decreased incidence of MB. This may involve accelerated biotransformation of imipramine HC1 e.g. by ring hydroxylation. Such a process could create a greater number of polar metabolites which are less amphiphilic than the parent com-pound and, therefore, do not have the ability to bind with phospholipid (5). Another explanation for fewer MB as a function of time may be that amphiphilic drug molecules undergo biotransformation into more hydrophilic metabolites which no longer have an increased affinity for polar lipids (25). While both of these hypothesis are possible, the ability of cells to metabolically adapt would probably occur before one year of treatment.
For a cell to develop phospholipidosis it must, under normal conditions, catabolize enough polar lipid to complex with a given amphiphile (24) . Phospholipid content in liver, kidney and brain decreases in aging albino rats (1,8) . This may also occur in other organs with advancing age. Since the tissues examined in this study were from older animals, cells may have had less opportunity to interact with phospholipid because of decreased levels. This may have reduced MB formation. Obviously, work needs to be done to uncover the mechanism(s) through which MB become reduced with chronicity of drug treatment.
